Answers are grounded in this paper and cite their sources.
Assessment of the effectiveness of a drug is a complex process. Currently, the standard method for assessing the effectiveness of a medical intervention is the quality-adjusted life years (QALY). In the summer of 2024, a description of a new method for assessing the effectiveness of medical interventions — Standard of Living Valuation (SoLV) was published. The proposed method is more difficult than QALY, but its capabilities are broader. However, this method is also not optimal. The problem of creating an optimal method for assessing the cost-effectiveness of health technologies remains open.
No takes yet. Share an insight, caveat, or question.
Busheva et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: